Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	71.64	86.89	38.25	84.7	19.84
Cash & Short-Term Investments	71.64	86.89	38.25	84.7	19.84
Cash Growth	-17.55%	127.16%	-54.84%	326.96%	-26.97%
Other Receivables	-	0.25	0.91	0.55	0.6
Receivables	-	0.25	0.91	0.55	0.6
Prepaid Expenses	1.57	1.19	1.61	2.29	0.04
Other Current Assets	2.6	0.62	0.96	0.29	0.2
Total Current Assets	75.81	88.94	41.73	87.83	20.69
Property, Plant & Equipment	2.85	4.19	5.45	4.83	2.03
Other Long-Term Assets	1.24	1.76	1.18	0.99	0.64
Total Assets	79.9	94.89	48.36	93.65	23.36
Accounts Payable	4.03	4.15	1.77	3.92	1.42
Accrued Expenses	9.52	6.94	4.24	2.81	2.05
Current Portion of Leases	1.09	0.97	0.87	0.51	-
Other Current Liabilities	0.6	0.32	0.19	0.79	0.55
Total Current Liabilities	15.24	12.37	7.07	8.02	4.01
Long-Term Leases	0.72	1.81	2.79	2.38	1.62
Long-Term Unearned Revenue	2.26	2.26	2.26	0.6	0.6
Other Long-Term Liabilities	-	-	0.26	13.14	8.41
Total Liabilities	18.23	16.45	12.37	24.14	14.65
Common Stock	0	0	-	0	0
Additional Paid-In Capital	302.54	248.04	141.12	136.96	1.68
Retained Earnings	-240.87	-169.6	-105.14	-67.45	-36.81
Total Common Equity	61.67	78.44	35.99	69.52	-35.13
Shareholders' Equity	61.67	78.44	35.99	69.52	8.71
Total Liabilities & Equity	79.9	94.89	48.36	93.65	23.36
Total Debt	1.81	2.79	3.65	2.89	1.62
Net Cash (Debt)	69.82	84.1	34.6	81.82	18.21
Net Cash Growth	-16.98%	143.07%	-57.71%	349.19%	-32.95%
Net Cash Per Share	4.79	8.06	9.48	71.81	105.29
Filing Date Shares Outstanding	15.02	15.06	10.94	4.95	10.16
Total Common Shares Outstanding	15.02	11.16	4.62	4.95	9.81
Working Capital	60.57	76.56	34.67	79.81	16.67
Book Value Per Share	4.11	7.03	7.78	14.04	-3.58
Tangible Book Value	61.67	78.44	35.99	69.52	-35.13
Tangible Book Value Per Share	4.11	7.03	7.78	14.04	-3.58
Machinery	2.88	2.62	2.35	1.92	0.44
Leasehold Improvements	2.71	2.48	2.48	2.06	0.26

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q